Global, regional and national burden of male infertility in 204 countries and territories between 1990 and 2019: an analysis of global burden of disease study.
Global burden of disease
Male infertility
Socio-demographic index
Years lived with disability
Journal
BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562
Informations de publication
Date de publication:
08 11 2023
08 11 2023
Historique:
received:
21
06
2023
accepted:
19
09
2023
medline:
10
11
2023
pubmed:
9
11
2023
entrez:
8
11
2023
Statut:
epublish
Résumé
Many countries and regions have experienced male fertility problems due to various influencing factors, especially in less developed countries. Unlike female infertility, male infertility receives insufficient attention. Understanding the changing patterns of male infertility in the world, different regions and different countries is crucial for assessing the global male fertility and reproductive health. We obtained data on prevalence, years of life lived with disability (YLD), age-standardized rates of prevalence (ASPR) and age-standardized YLD rate (ASYR) from the Global Burden of Disease Study 2019. We analyzed the burden of male infertility at all levels, including global, regional, national, age stratification and Socio-demographic Index (SDI). In 2019, the global prevalence of male infertility was estimated to be 56,530.4 thousand (95% UI: 31,861.5-90,211.7), reflecting a substantial 76.9% increase since 1990. Furthermore, the global ASPR stood at 1,402.98 (95% UI: 792.24-2,242.45) per 100,000 population in 2019, representing a 19% increase compared to 1990. The regions with the highest ASPR and ASYR for male infertility in 2019 were Western Sub-Saharan Africa, Eastern Europe, and East Asia. Notably, the prevalence and YLD related to male infertility peaked in the 30-34 year age group worldwide. Additionally, the burden of male infertility in the High-middle SDI and Middle SDI regions exceeded the global average in terms of both ASPR and ASYR. The global burden of male infertility has exhibited a steady increase from 1990 to 2019, as evidenced by the rising trends in ASPR and ASYR, particularly in the High-middle and Middle SDI regions. Notably, the burden of male infertility in these regions far exceeds the global average. Additionally, since 2010, there has been a notable upward trend in the burden of male infertility in Low and Middle-low SDI regions. Given these findings, it is imperative to prioritize efforts aimed at improving male fertility and reproductive health.
Sections du résumé
BACKGROUND
Many countries and regions have experienced male fertility problems due to various influencing factors, especially in less developed countries. Unlike female infertility, male infertility receives insufficient attention. Understanding the changing patterns of male infertility in the world, different regions and different countries is crucial for assessing the global male fertility and reproductive health.
METHODS
We obtained data on prevalence, years of life lived with disability (YLD), age-standardized rates of prevalence (ASPR) and age-standardized YLD rate (ASYR) from the Global Burden of Disease Study 2019. We analyzed the burden of male infertility at all levels, including global, regional, national, age stratification and Socio-demographic Index (SDI).
RESULTS
In 2019, the global prevalence of male infertility was estimated to be 56,530.4 thousand (95% UI: 31,861.5-90,211.7), reflecting a substantial 76.9% increase since 1990. Furthermore, the global ASPR stood at 1,402.98 (95% UI: 792.24-2,242.45) per 100,000 population in 2019, representing a 19% increase compared to 1990. The regions with the highest ASPR and ASYR for male infertility in 2019 were Western Sub-Saharan Africa, Eastern Europe, and East Asia. Notably, the prevalence and YLD related to male infertility peaked in the 30-34 year age group worldwide. Additionally, the burden of male infertility in the High-middle SDI and Middle SDI regions exceeded the global average in terms of both ASPR and ASYR.
CONCLUSION
The global burden of male infertility has exhibited a steady increase from 1990 to 2019, as evidenced by the rising trends in ASPR and ASYR, particularly in the High-middle and Middle SDI regions. Notably, the burden of male infertility in these regions far exceeds the global average. Additionally, since 2010, there has been a notable upward trend in the burden of male infertility in Low and Middle-low SDI regions. Given these findings, it is imperative to prioritize efforts aimed at improving male fertility and reproductive health.
Identifiants
pubmed: 37940907
doi: 10.1186/s12889-023-16793-3
pii: 10.1186/s12889-023-16793-3
pmc: PMC10631182
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2195Informations de copyright
© 2023. The Author(s).
Références
J Androl. 2009 Sep-Oct;30(5):541-7
pubmed: 19201701
Clin Biochem. 2018 Dec;62:2-10
pubmed: 29555319
Hum Reprod Update. 2015 Jul-Aug;21(4):411-26
pubmed: 25801630
Hum Reprod Update. 2023 Mar 1;29(2):157-176
pubmed: 36377604
Prz Menopauzalny. 2022 Mar;21(1):47-63
pubmed: 35388278
Reprod Biol Endocrinol. 2015 Apr 26;13:37
pubmed: 25928197
Spine (Phila Pa 1976). 2022 Nov 1;47(21):1532-1540
pubmed: 35857624
Lancet. 2020 Oct 17;396(10258):1285-1306
pubmed: 32679112
Urologia. 2018 Feb;85(1):22-24
pubmed: 28967062
Fertil Steril. 2005 Dec;84(6):1657-61
pubmed: 16359960
Hum Reprod Update. 2023 Jan 5;29(1):126-154
pubmed: 36130055
Urology. 2022 Nov;169:9-16
pubmed: 35905774
Andrologia. 2022 Aug;54(7):e14434
pubmed: 35484935
Nat Rev Urol. 2017 Feb;14(2):120-130
pubmed: 28050014
Hum Reprod. 1999 Mar;14(3):731-5
pubmed: 10221705
Fertil Steril. 2019 Jun;111(6):1047-1053
pubmed: 31155114
Asian J Androl. 2018 Jul-Aug;20(4):379-384
pubmed: 29493550
Acta Clin Croat. 2019 Sep;58(3):508-515
pubmed: 31969764
Sci Rep. 2023 Apr 26;13(1):6819
pubmed: 37100822
Bull World Health Organ. 1976;54(3):319-41
pubmed: 798639
J Hum Reprod Sci. 2008 Jan;1(1):15-8
pubmed: 19562058
Medicina (Kaunas). 2022 Sep 04;58(9):
pubmed: 36143894
Arh Hig Rada Toksikol. 2021 Jun 28;72(3):101-113
pubmed: 34187108
Hum Reprod. 2013 Feb;28(2):462-70
pubmed: 23213178
Aging (Albany NY). 2019 Dec 2;11(23):10952-10991
pubmed: 31790362
Hum Reprod Update. 2017 Jul 1;23(4):458-480
pubmed: 28333354
Basic Clin Androl. 2021 May 6;31(1):8
pubmed: 33952196
Chin J Physiol. ;59(6):355-365
pubmed: 27817197
Reprod Biomed Online. 2021 Feb;42(2):442-450
pubmed: 33246804
Hum Reprod. 2011 May;26(5):1012-6
pubmed: 21382832
Eur Urol. 2016 Oct;70(4):635-645
pubmed: 27113031
Diagnostics (Basel). 2022 Nov 28;12(12):
pubmed: 36552986
Physiol Rev. 2016 Jan;96(1):55-97
pubmed: 26582516
BMJ. 1992 Sep 12;305(6854):609-13
pubmed: 1393072
Minerva Endocrinol (Torino). 2022 Mar;47(1):77-88
pubmed: 34825558
Reprod Biol Endocrinol. 2018 Oct 23;16(1):103
pubmed: 30352581
Minerva Ginecol. 1999 Jun;51(6):223-31
pubmed: 10479874
J Assist Reprod Genet. 2002 Jun;19(6):284-90
pubmed: 12166634
Curr Opin Urol. 2017 Sep;27(5):441-445
pubmed: 28661897
J Obstet Gynaecol. 2022 Oct;42(7):2583-2587
pubmed: 35959847
Aust Fam Physician. 2017 Sep;46(9):641-646
pubmed: 28892594
Nutrients. 2022 Sep 28;14(19):
pubmed: 36235694
Lancet. 2020 Oct 17;396(10258):1204-1222
pubmed: 33069326